Unknown PHASE2/PHASE3 INTERVENTIONAL 3-arm NCT00815893

The Feasibility of Dexmedetomidine for Awake Fiberoptic Nasal Intubation

Interventional Study of Dexmedetomidine for Sedating Anticipated Difficult Airway Patients Undergoing Awake Fiberoptic Nasal Intubation

Sponsor: Kaohsiung Medical University Chung-Ho Memorial Hospital

Conditions Awake Fiberoptic Nasal Intubation

Interventions Normal Saline 0.9% dexmedetomidine propofol 1%

Updated 6 times since 2017 Last updated: Jul 27, 2009 Started: Aug 31, 2008 Primary completion: Aug 31, 2009 Completion: Aug 31, 2009

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE2/PHASE3 clinical study on Awake Fiberoptic Nasal Intubation, this trial is ongoing. The trial is conducted by Kaohsiung Medical University Chung-Ho Memorial Hospital and has accumulated 6 data snapshots since 2008. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

6 versions recorded

Sep 2025 — Present [monthly]

Unknown PHASE2/PHASE3
Sep 2024 — Sep 2025 [monthly]

Unknown PHASE2/PHASE3
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE2/PHASE3

Status: Unknown Status → Unknown · Phase: PHASE2_PHASE3 → PHASE2/PHASE3
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE2_PHASE3
Jun 2018 — Jan 2021 [monthly]

Unknown Status PHASE2_PHASE3

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Unknown Status PHASE2_PHASE3

First recorded

Aug 2008

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Kaohsiung Medical University Chung-Ho Memorial Hospital

Data source: Kaohsiung Medical University Chung-Ho Memorial Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Kaohsiung City, Taiwan